Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.
about
Control of RANKL gene expressionActivated human T cells express alternative mRNA transcripts encoding a secreted form of RANKLModulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancerControl of bone mass and remodeling by PTH receptor signaling in osteocytesOsteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling BoneThe estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription.Comparative genomics reveals a functional thyroid-specific element in the far upstream region of the PAX8 gene.Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype.Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response elementTissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration.The RUNX2 cistrome in osteoblasts: characterization, down-regulation following differentiation, and relationship to gene expression.Imipramine Protects against Bone Loss by Inhibition of Osteoblast-Derived MicrovesiclesA downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3.The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3).Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3.Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system.Kruppel-like factor 4 expression in osteoblasts represses osteoblast-dependent osteoclast maturation.Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis.Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats.Transcriptional regulation of the human TNFSF11 gene in T cells via a cell type-selective set of distal enhancers.Mouse Rankl expression is regulated in T cells by c-Fos through a cluster of distal regulatory enhancers designated the T cell control regionActivation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancersGenome-wide principles of gene regulation by the vitamin D receptor and its activating ligandSelective Distal Enhancer Control of the Mmp13 Gene Identified through Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Genomic Deletions.The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3.The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice.Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor.Genome-scale techniques highlight the epigenome and redefine fundamental principles of gene regulation.Regulation of mouse Cyp24a1 expression via promoter-proximal and downstream-distal enhancers highlights new concepts of 1,25-dihydroxyvitamin D(3) action.The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.Role of DNA methylation in the regulation of the RANKL-OPG system in human bone.An RNA-independent linkage of noncoding transcription to long-range enhancer function.Control of bone resorption in mice by Schnurri-3.Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged boneOsteocyte RANKL: new insights into the control of bone remodelingMKP-1 is essential for canonical vitamin D-induced signaling through nuclear import and regulates RANKL expression and function.
P2860
Q24619669-61E8132F-DEF4-43F8-8E64-F357DD441331Q24632345-29F5340E-D7CA-4B9A-9B09-7609D9DF3CC0Q24654971-74B9370E-D1BF-4734-9FB4-8A1B540EC599Q27300741-1BBA0FDF-D324-4A6E-AECF-C73ECE4FF701Q28267634-3F5DFAAC-CEF9-4F51-9F53-94F111889DCFQ28393372-D8C5F32A-29A4-4A40-8B1C-5CD055C2DA1CQ28572351-7099A6A1-89E5-4619-A971-1445C6AB568AQ33576499-ADD7F6D5-4186-4F1B-87AB-814FE0793E41Q33578274-8C97DB7C-A25D-49AD-84CD-AF3C35316F56Q33610663-AC62B87F-C718-4DB4-A966-1789ECB2367AQ33663401-A5CFF945-BFB9-45DA-8A48-3EE487ACAC69Q33694018-1B5BFC9A-0ED8-4F85-A922-F12D4E45ECACQ33718442-C952AB54-C8DB-4D48-B561-94C9E1341DECQ33755136-8C341E08-43F5-433A-A768-CB93D414A484Q33832689-3A4183E5-A17A-49BE-9E4D-B028B0A9FB31Q33888800-B5813DAF-BB72-4F8B-9A05-DB7D1F389DDEQ33901231-19830D17-4F74-4856-B654-B67554639DB7Q33949697-25A8D96C-1022-44E9-B775-603B0C9C7949Q34017216-98405E3A-9AD3-4FA2-8BAF-665053008274Q34291256-17DA0D0C-49E1-4F31-BFA8-4CE32788DEFCQ34424720-27E341EB-09C1-43BB-AE77-0E866706827EQ34541607-EAC5A9BB-38E5-49BE-9364-87E1E0EC13E5Q34702403-D2886504-67FE-4011-A027-D1562BCEF443Q35001309-3D5B52DD-7C07-4D65-A123-0618E3E5B796Q35063276-835757B8-9CA8-4BCF-BD78-4AA126A67D21Q35071128-79B40D1E-28A6-4E12-B7CA-B7F4ED5006B1Q35230672-C6F527B9-69B1-4CB1-9D46-017367E5E1D6Q35536330-789F739C-0B9E-4865-A98B-8FE0092DD56AQ35664750-8C391978-E529-4C32-AC03-0F9D5F75CF19Q35744006-2DF3B326-0351-4231-A06B-6821097B1417Q35793023-BB08EA69-40D6-4575-86B5-E13F2FACC8F2Q35853981-EE9D2180-0049-4255-980A-754F8AF93CE0Q35858723-52897E3B-E060-4D4C-8EBF-D9BC2EEE9DDDQ35860566-D4B2E271-46CB-4D8B-8515-29A7EED02177Q35916106-47405BE2-FEA9-4294-924D-2632B8A435CFQ35943957-66C2CFFB-90BB-4898-97EF-CB0005C4CCCFQ35991486-653E6977-B3F2-4E4D-B911-7011895EFE87Q36157326-B4BEBC03-E14E-474A-8D36-65582724A3C3Q36253514-4BE9ADE5-25F4-47EA-9CD0-2AC281871A3DQ36279507-E42DDB53-B539-419E-922A-3AD7FDB68A04
P2860
Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Parathyroid hormone controls r ...... tant transcriptional enhancer.
@ast
Parathyroid hormone controls r ...... tant transcriptional enhancer.
@en
type
label
Parathyroid hormone controls r ...... tant transcriptional enhancer.
@ast
Parathyroid hormone controls r ...... tant transcriptional enhancer.
@en
prefLabel
Parathyroid hormone controls r ...... tant transcriptional enhancer.
@ast
Parathyroid hormone controls r ...... tant transcriptional enhancer.
@en
P2093
P2860
P356
P1476
Parathyroid hormone controls r ...... tant transcriptional enhancer.
@en
P2093
Charles A O'Brien
Stavros C Manolagas
P2860
P304
P356
10.1128/MCB.00356-06
P407
P577
2006-09-01T00:00:00Z